- New Generation BTK Inhibitors in R/R CLL: Resistance Mechanism and Optimizing Sequential Therapies
- Polycythemia Vera and Myelofibrosis: Current and Future JAKi Therapies in MPNs
- Follicular lymphoma: New approaches
- Real World Oncology: Translating Data to Clinical Practice
- Evolving Shifts in 1L Chemo/IO Therapies for Previously Untreated LBCL
- Advances in Oncology: CAR T Therapies in LBCL
- ASCO & EHA 2025 updates
OncLive® State of the Science Summit™: Hematologic Malignancies
The Kahler Grand Hotel
20 2nd Ave Southwest
Rochester, Minnesota 55902
Thursday, August 7, 2025
6:00 PM-9:00 PM CDT
Complimentary Parking
In-Person Only
Event Chair
Naseema Gangat, MBBS
Mayo Clinic Comprehensive Cancer Center
OVERVIEW
OncLive® State of the Science Summit™ (SOSS) are in-person meetings designed for academic & community-based physicians and health care professionals that provide education on the science driving updates in cancer management and the associated clinical benefits for patients. SOSS attendees will improve their knowledge of novel treatment approaches and reinforce their confidence in applying state-of-the-art treatment strategies.
Registration for this Summit is complimentary.
TOPICS INCLUDE:
Venue Location
OncLive - an MJH Life Sciences brand
Copyright 2025 (C) Intellisphere, LLC
2 Commerce Drive
Cranbury, NJ 08512